SE327253B - - Google Patents
Info
- Publication number
- SE327253B SE327253B SE13232/62A SE1323262A SE327253B SE 327253 B SE327253 B SE 327253B SE 13232/62 A SE13232/62 A SE 13232/62A SE 1323262 A SE1323262 A SE 1323262A SE 327253 B SE327253 B SE 327253B
- Authority
- SE
- Sweden
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1429161 | 1961-12-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE327253B true SE327253B (pl) | 1970-08-17 |
Family
ID=4399594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE13232/62A SE327253B (pl) | 1961-12-08 | 1962-12-07 |
Country Status (6)
Country | Link |
---|---|
US (1) | US3247063A (pl) |
BE (1) | BE643068A (pl) |
FR (1) | FR2227M (pl) |
GB (1) | GB997727A (pl) |
NL (2) | NL286444A (pl) |
SE (1) | SE327253B (pl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3548052A (en) * | 1964-10-27 | 1970-12-15 | Canada Packers Ltd | Heparin compositions and methods of using same |
US3482014A (en) * | 1966-06-29 | 1969-12-02 | Canada Packers Ltd | Orally active heparin and method for making and using same |
US3546338A (en) * | 1967-03-30 | 1970-12-08 | American Cyanamid Co | Heparin composition |
US3444093A (en) * | 1968-01-29 | 1969-05-13 | Burton Parsons Chemicals Inc | Self-mixing anticoagulant composition |
US3903266A (en) * | 1972-05-03 | 1975-09-02 | Ralph C Robbins | Compositions and methods for disaggregating blood cells |
US4021544A (en) * | 1976-07-12 | 1977-05-03 | American Cyanamid Company | Complement inhibitors |
US4098995A (en) * | 1976-07-12 | 1978-07-04 | American Cyanamid Company | Polygalactosido-sucrose poly(h-)sulfate salts |
US4188188A (en) * | 1978-09-27 | 1980-02-12 | Bio-Rad Laboratories, Inc. | High density lipoprotein cholesterol assay |
US4281108A (en) * | 1980-01-28 | 1981-07-28 | Hepar Industries, Inc. | Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained |
IT1214609B (it) * | 1985-05-17 | 1990-01-18 | Opocrin Spa | Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono. |
FR2584728B1 (fr) * | 1985-07-12 | 1987-11-20 | Choay Sa | Procede de sulfatation de glycosaminoglycanes et de leurs fragments |
CA1327354C (en) * | 1987-03-19 | 1994-03-01 | David Cullis-Hill | Anti-inflamatory compounds and compositions |
US5668116A (en) * | 1987-03-19 | 1997-09-16 | Anthropharm Pty. Limited | Anti-inflammatory compounds and compositions |
FR2622450B1 (fr) * | 1987-11-03 | 1991-02-22 | Sanofi Sa | Association heparine/dermatane sulfate |
GB8826448D0 (en) * | 1988-11-11 | 1988-12-14 | Thrombosis Res Inst | Improvements in/relating to organic compounds |
US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
-
0
- NL NL123338D patent/NL123338C/xx active
- NL NL286444D patent/NL286444A/xx unknown
-
1962
- 1962-11-29 GB GB45156/62A patent/GB997727A/en not_active Expired
- 1962-12-05 US US242380A patent/US3247063A/en not_active Expired - Lifetime
- 1962-12-07 SE SE13232/62A patent/SE327253B/xx unknown
- 1962-12-07 FR FR917876A patent/FR2227M/fr active Active
-
1964
- 1964-01-28 BE BE643068A patent/BE643068A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB997727A (en) | 1965-07-07 |
US3247063A (en) | 1966-04-19 |
BE643068A (pl) | 1964-05-15 |
NL286444A (pl) | |
FR2227M (fr) | 1963-12-23 |
NL123338C (pl) |